McElhenny Sheffield Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $327K | Hold |
806
| – | – | 0.09% | 81 |
|
|
2025
Q1 | $401K | Buy |
806
+5
| +0.6% | +$2.49K | 0.15% | 72 |
|
|
2024
Q4 | $417K | Buy |
801
+1
| +0.1% | +$520 | 0.14% | 65 |
|
|
2024
Q3 | $495K | Hold |
800
| – | – | 0.16% | 58 |
|
|
2024
Q2 | $442K | Hold |
800
| – | – | 0.15% | 61 |
|
|
2024
Q1 | $465K | Hold |
800
| – | – | 0.17% | 57 |
|
|
2023
Q4 | $425K | Hold |
800
| – | – | 0.17% | 57 |
|
|
2023
Q3 | $405K | Hold |
800
| – | – | 0.21% | 55 |
|
|
2023
Q2 | $417K | Sell |
800
-4
| -0.5% | -$2.09K | 0.18% | 57 |
|
|
2023
Q1 | $463K | Sell |
804
-1
| -0.1% | -$576 | 0.24% | 59 |
|
|
2022
Q4 | $443K | Buy |
805
+5
| +0.6% | +$2.75K | 0.21% | 57 |
|
|
2022
Q3 | $406K | Hold |
800
| – | – | 0.31% | 50 |
|
|
2022
Q2 | $435K | Hold |
800
| – | – | 0.2% | 60 |
|
|
2022
Q1 | $473K | Hold |
800
| – | – | 0.17% | 70 |
|
|
2021
Q4 | $534K | Hold |
800
| – | – | 0.2% | 69 |
|
|
2021
Q3 | $457K | Buy |
+800
| New | +$457K | 0.21% | 76 |
|